Rajesh Malik - Feb 1, 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Medical Officer
Signature
/s/ James Stillman Hanson, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Feb 1, 2022
Transactions value $
$3,000
Form type
4
Date filed
2/2/2022, 04:20 PM
Previous filing
Jan 5, 2022
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $3K +10K +15.66% $0.30* 73.9K Feb 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Option (Right to Buy) Options Exercise $0 -10K -15.38% $0.00 55K Feb 1, 2022 Common Stock 10K $0.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents (i) 53,605 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
F2 All shares underlying this option have vested.